Command Palette

Search for a command to run...

Preprint WatchMildSeptember 3rd, 2026

Abundant Glomerular Neutrophil Extracellular Traps in C3 Glomerulopathy

O'Sullivan, K.; khandelwal, p.; Walker, P. D.; hickey, m.; Licht, C.

Introduction: C3 glomerulopathy (C3G) is driven by fluid-phase alternative complement pathway dysregulation, with emerging evidence linking glomerular neutrophil infiltration to disease severity.

Mild contradiction

1 prior failure

One documented clinical failure (Phase 1 or 2) overlaps with the claimed mechanism.

This preprint reports abundant glomerular neutrophil extracellular traps in biopsies from 33 patients with C3 glomerulopathy and positions NET formation downstream of fluid-phase alternative pathway dysregulation. Claidex holds one C3 failure, pegcetacoplan in delayed graft function after deceased-donor kidney transplantation (pegcetacoplan-c3-delayed-graft-function-phase3-strategic-reprioritization), a Phase 3 withdrawn at zero enrollment and classified strategic_reprioritization rather than efficacy_failure. The flag is MILD and the read-across is limited: that failure produced no efficacy data, and C3 glomerulopathy is an indication where C3 carries strong association support (Open Targets 0.5956) unlike the transplant ischaemia-reperfusion setting (acute kidney injury proxy 0.0878). The relevant caution is narrower than the target label suggests. A NET-driven effector mechanism sits downstream of C3 cleavage, so it would not be neutralised by upstream C3 blockade alone, and programs citing this work as support for C3 inhibition should state whether their endpoint depends on the cleavage step or on the neutrophil effector arm.

Abstract excerpt

Introduction: C3 glomerulopathy (C3G) is driven by fluid-phase alternative complement pathway dysregulation, with emerging evidence linking glomerular neutrophil infiltration to disease severity. Neutrophil extracellular traps (NETs) are implicated in other forms of glomerulonephritis. However, their participation in the pathogenesis of C3G remains undefined. Methods: Kidney biopsies from 33 patients with C3G (15 with dense deposit disease [DDD] and 18 with C3 glomerulonephritis [C3GN]) were compared with 15 anti-neutrophil cytoplasmic antibody associated vasculitis (AAV) biopsies as a neutrophil-rich disease control in this retrospective cross-sectional study. Glomerular neutrophils and NETs were identified using immunofluorescence, staining for myeloperoxidase, citrullinated histone H3, peptidyl arginine deiminase-4, and DNA. Supervised machine learning was used to quantify glomerular NET formation, and the data were correlated with kidney function at time of biopsy using linear regression. Results: Intraglomerular NETs were abundant and detected in the majority of glomeruli in C3G biopsies. Compared with AAV, C3G showed a significantly higher fraction of neutrophils forming NETs, despite similar neutrophil counts per glomerulus. NET abundance was similar in DDD and C3GN. In exploratory analyses, a greater proportion of glomeruli containing NETs was associated with lower kidney function (estimated glomerular filtration rate) at biopsy, and this association remained significant after adjustment for age, C3G subtype, and interstitial fibrosis. Conclusions: These observations demonstrate that intraglomerular NETs are a common and prominent observation in C3G and are associated with reduced kidney function at biopsy. These findings raise the possibility that NET deposition in glomeruli is a previously unrecognized driver of glomerular injury in C3G.

Matching Claidex post-mortems

1 of 1 indexed

This is an automated contradiction flag, not an editorial judgment on the preprint's quality. Flags identify where the preclinical literature and the clinical failure record diverge.